- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/36 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class A61K 38/36
Total number of patents in this class: 1096
10-year publication summary
|
82
|
99
|
84
|
82
|
75
|
58
|
76
|
48
|
48
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2699 |
31 |
| Bioverativ Therapeutics Inc. | 212 |
27 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 298 |
24 |
| CSL Behring GmbH | 348 |
23 |
| The Children's Hospital of Philadelphia | 867 |
20 |
| Baxter International Inc. | 1885 |
17 |
| Baxter Healthcare S.A. | 1393 |
17 |
| Ethicon, Inc. | 1117 |
14 |
| Omrix Biopharmaceuticals Ltd. | 150 |
14 |
| Quiapeg Pharmaceuticals AB | 38 |
12 |
| KM Biologics Co., Ltd | 93 |
12 |
| The Regents of the University of California | 20842 |
10 |
| Mayo Foundation for Medical Education and Research | 3398 |
10 |
| Asahi Kasei Pharma Corporation | 115 |
10 |
| Modernatx, Inc. | 1282 |
10 |
| Octapharma AG | 199 |
10 |
| Combangio, Inc. | 29 |
9 |
| The Board of Trustees of the University of Illinois | 2753 |
8 |
| St. Teresa Medical, Inc. | 28 |
8 |
| Immunitybio, Inc. | 511 |
8 |
| Other owners | 802 |